Sales Update
Filed with ASX · · 2 pages · English
On 6ix: 6ix.com/news/sales-update-3
Adelaide, Australia, 25 November 2020 – Nova Eye Medical Limited (ASX: EYE), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today provides an update on the sales performance of the Company’s glaucoma surgical device business for the four-month period ended 31 October 2020. ® Comprising the Company’s proprietary iTrack™ and Molteno3 technologies, w
In the deck
Story so far
Earlier from Nova Eye Medical
- Establishment of AlpaRET
- FY20 Results presentation
- FY 20 Results
- Full Year Statutory Accounts
- Australian Tax Office Class Ruling on Capital Gain
Later from Nova Eye Medical
- Half Year Results Discussion
- Investor presentation Half year Results 31 December 2020
- Clinical trial to Assess Efficacy and Safety of i Track
- 2RT Post LEAD Review Shows Improved Treatment Benefits
- First Patient enrolled in MAGIC Clinical Trial
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical